← Evidence map

TrialOncotarget2016

Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer.

Ijeoma Umelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26689995